Oral Drugs in Immunology
Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
Advanced Development Pipeline
Differentiated Programs in Clinical Development
Immunic is developing orally administered, small molecule programs, each of which has unique features intended to directly address the unmet needs of patients with serious chronic inflammatory and autoimmune diseases.
Treating Multiple Sclerosis
Elevate the Standard of Care With a Holistic Solution for Multiple Sclerosis Patients
Our mission is to develop high-quality, oral treatment options with comprehensive therapeutic efficacy and outstanding safety and tolerability for patients with multiple sclerosis.
Treating Celiac Disease
Making New, Convenient, Oral Treatment Options Available to Celiac Disease Patients
We aim to offer new, efficacious, safe and well-tolerated orally available treatment options to patients suffering from celiac disease in order to improve their lives by eliminating the debilitating symptoms of the disease.